{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:23:21Z","timestamp":1789219401235,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the outcomes of intravitreal gas and anti\u2013vascular endothelial growth factor (anti-VEGF), with or without tissue plasminogen activator (tPA), injection for submacular hemorrhage (SMH).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors retrospectively enrolled patients with SMH treated with intravitreal gas and anti-VEGF, with or without tPA (tPA and non-tPA groups, respectively), injection between 2014 and 2021, and data were collected at the preoperative visit and at 1-, 3-, 6-, and 12-month follow-ups. The primary outcome was the final best-corrected visual acuity, and the secondary outcomes were central subfield thickness, degree of blood displacement, and incidence of vitreous hemorrhage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Herein, 38 eyes received intravitreal gas, anti-VEGF, and tPA injections, whereas 89 eyes received intravitreal gas and anti-VEGF injections. At 12 months, no significant intergroup difference was detected (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.94), except the slightly greater central subfield thickness change in the non-tPA group (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03). Complete SMH displacement occurred in 35 (tPA = 92.1%) and 89 (non-tPA = 89.9%) eyes, with higher vitreous hemorrhage incidence in the non-tPA group (odds ratio 7.03, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In pneumatic displacement combined with anti-VEGF therapy in SMH, adjunctive tPA use did not alter the visual and anatomical outcomes, although the vitreous hemorrhage risk in large SMH was reduced.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004337","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T17:07:34Z","timestamp":1732554454000},"page":"394-401","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["PNEUMATIC DISPLACEMENT AND INTRAVITREAL ANTI\u2013VASCULAR ENDOTHELIAL GROWTH FACTOR, WITH OR WITHOUT INTRAVITREAL TISSUE PLASMINOGEN ACTIVATOR, INJECTION FOR SUBMACULAR HEMORRHAGE"],"prefix":"10.1097","volume":"45","author":[{"given":"Patraramon","family":"Chotikkakamthorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patama","family":"Bhurayanontachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pichai","family":"Jirarattanasopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wantanee Dangboon","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thada","family":"Tantisarasart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansing","family":"Ratanasukon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250226","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archopht.1991.01080050139046","article-title":"Fibrin directs early retinal damage after experimental subretinal hemorrhage","volume":"109","author":"Toth","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"R2-20250226","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(97)00089-1","article-title":"Pathophysiology and management of subretinal hemorrhage","volume":"42","author":"Hochman","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"R3-20250226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000380830","article-title":"Identification of underlying causes of spontaneous submacular hemorrhage by indocyanine green angiography","volume":"233","author":"Kim","year":"2015","journal-title":"Ophthalmologica"},{"key":"R4-20250226","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00055735-200006000-00009","article-title":"Pneumatic displacement of submacular hemorrhage","volume":"11","author":"Johnson","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"key":"R5-20250226","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ophtha.2013.11.004","article-title":"Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization","volume":"121","author":"Kim","year":"2014","journal-title":"Ophthalmology"},{"key":"R6-20250226","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1167\/iovs.05-1019","article-title":"A study of retinal penetration of intravitreal tenecteplase in pigs","volume":"47","author":"Kwan","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20250226","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006982-199515040-00009","article-title":"Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage","volume":"15","author":"Coll","year":"1995","journal-title":"Retina"},{"key":"R8-20250226","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00006982-199616060-00009","article-title":"The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model","volume":"16","author":"Boone","year":"1996","journal-title":"Retina"},{"key":"R9-20250226","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(99)00239-1","article-title":"A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits","volume":"128","author":"Kamei","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R10-20250226","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s004170050232","article-title":"Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas","volume":"237","author":"Hesse","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-20250226","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/jop.2013.0135","article-title":"Long-term visual outcome and its predictive factors following treatment of acute submacular hemorrhage with intravitreous injection of tissue plasminogen factor and gas","volume":"30","author":"Sobolewska","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"R12-20250226","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/sj.eye.6701769","article-title":"Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais","volume":"19","author":"Ratanasukon","year":"2005","journal-title":"Eye (Lond)"},{"key":"R13-20250226","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.eye.6703017","article-title":"Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration","volume":"23","author":"Fang","year":"2009","journal-title":"Eye (Lond)"},{"key":"R14-20250226","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/112067211002000305","article-title":"Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator","volume":"20","author":"Cakir","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"R15-20250226","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/IAE.0b013e318287d99d","article-title":"Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator","volume":"33","author":"Fujikawa","year":"2013","journal-title":"Retina"},{"key":"R16-20250226","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00417-011-1649-1","article-title":"Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator","volume":"249","author":"Mizutani","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R17-20250226","first-page":"852","article-title":"Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator","volume":"28","author":"Yang","year":"2005","journal-title":"Chang Gung Med J"},{"key":"R18-20250226","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1038\/s41598-022-18619-5","article-title":"Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy","volume":"12","author":"Mun","year":"2022","journal-title":"Sci Rep"},{"key":"R19-20250226","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/jcm12031035","article-title":"Efficacy evaluation of tissue plasminogen activator with anti-vascular endothelial growth factor drugs for submacular hemorrhage treatment: a meta-analysis","volume":"12","author":"He","year":"2023","journal-title":"J Clin Med"},{"key":"R20-20250226","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ophtha.2016.01.035","article-title":"Intravitreal tissue plasminogen activator, ranibizumab, and gas injection for submacular hemorrhage in polypoidal choroidal vasculopathy","volume":"123","author":"Kitagawa","year":"2016","journal-title":"Ophthalmology"},{"key":"R21-20250226","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/IAE.0b013e3181e37884","article-title":"Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration","volume":"31","author":"Guthoff","year":"2011","journal-title":"Retina"},{"key":"R22-20250226","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/tvst.10.14.34","article-title":"Conversion of central subfield thickness measurements of diabetic macular edema across cirrus and spectralis optical coherence tomography instruments","volume":"10","author":"Sun","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"R23-20250226","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archopht.1990.01070040116043","article-title":"Rebleeding in experimental traumatic hyphema treated with intraocular tissue plasminogen activator","volume":"108","author":"Williams","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R24-20250226","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archopht.116.10.1326","article-title":"Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator","volume":"116","author":"Ohji","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R25-20250226","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0161-6420(01)00648-0","article-title":"Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions","volume":"108","author":"Hattenbach","year":"2001","journal-title":"Ophthalmology"},{"key":"R26-20250226","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/IAE.0b013e31822528c8","article-title":"Vitreous hemorrhage complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage","volume":"31","author":"Wu","year":"2011","journal-title":"Retina"},{"key":"R27-20250226","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archopht.121.1.91","article-title":"Pathogenesis of the vitreous cloud emanating from subretinal hemorrhage","volume":"121","author":"Lincoff","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R28-20250226","doi-asserted-by":"crossref","first-page":"e0243201","DOI":"10.1371\/journal.pone.0243201","article-title":"Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration","volume":"15","author":"Lim","year":"2020","journal-title":"PLoS One"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T13:01:53Z","timestamp":1740574913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004337","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}